BRAINSTORM CELL THERAPEUTICS (BCLI)

US10501E2019 - Common Stock

0.533  0 (-0.28%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
0.000.000.000.000.00
Operating Expenses
21.44M24.82M24.54M31.68M23.00M
Research and Development
10.75M13.96M15.24M22.33M17.20M
Selling, General, and Administrative Expenses
10.69M10.87M9.30M9.36M5.80M
Operating Income
-21.44M-24.82M-24.54M-31.68M-23.00M
Interest Income/Expense
4.69MN/AN/AN/AN/A
Other Income/Expense
-447.00K550.00K80.00K-130.00K-250.00K
Income Before Taxes
-17.19M-24.28M-24.46M-31.81M-23.25M
Income Tax
N/AN/AN/AN/AN/A
Net Income
-17.19M-24.28M-24.46M-31.81M-23.25M
EBITDA
-21.17M-24.53M-24.28M-31.46M-22.84M
 
Per Share Data
EPS Diluted Total Ops
-0.40-0.66-0.68-1.07-1.06
Non GAAP EPS
N/A-0.66-0.68-1.08-1.06
 
Statistics

All data in USD

Charts